A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressively neurodegenerative disorder, which seriously affects human health and cannot be stopped by current treatments. Type 2 diabetes mellitus (T2DM) is a risk factor for AD. Our recent studies reported the neuroprotective effects of a GLP-1/GIP/Glucagon receptor triagonist (Triagonist), a novel unimolecular anti-diabetic drug, in cognitive and pathological improvements of 3xTg-AD mice. However, the detailed electrophysiological and molecular mechanisms underlying neuroprotection remain unexplored. The present study investigated the underlying electrophysiological and molecular mechanisms further by using whole-cell patch clamp techniques. Our results revealed that chronic Triagonist treatment effectively reduced working memory and reference memory errors of 3xTg-AD mice in a radial maze test. In addition, the Triagonist increased spontaneous excitatory synaptic activities, differentially modulated voltage- and chemically-gated Ca2+ flux, and reduced the over-excitation of pyramidal neurons in hippocampal slices of 3xTg-AD mice. In addition, chronic Triagonist treatment also up-regulated the expression levels of synaptophysin and PSD-95 in the hippocampus of 3xTg-AD mice. These results indicate that the Triagonist could improve memory formation, as well as synaptic transmission, Ca2+ balance, and neuronal excitability in 3xTg-AD mice. These neuroprotective effects of Triagonist may be involved in the up-regulation of synaptophysin and PSD-95. Therefore, the study suggests that multi-receptor agonists might be a novel therapeutic strategy for the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
A Brief History of Long-Term Potentiation
Nicoll, R. A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.015 · Cited by 841
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Research works printed but not linked: 74
- Arsenault, 2011, DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice, PloS One, 6, e17397, 10.1371/journal.pone.0017397 · DOI · Paper page
- Becher, 1999, The synaptophysin-synaptobrevin complex: a hallmark of synaptic vesicle maturation, J. Neurosci., 19, 1922, 10.1523/JNEUROSCI.19-06-01922.1999 · DOI · Paper page
- Bliss, 1993, A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0 · DOI · Paper page
- Busche, 2008, Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease, Science, 321, 1686, 10.1126/science.1162844 · DOI · Paper page
- Calhoun, 1996, Comparative evaluation of synaptophysin-based methods for quantification of synapses, J. Neurocytol., 25, 821, 10.1007/BF02284844 · DOI · Paper page
- Celone, 2006, Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis, J. Neurosci., 26, 10222, 10.1523/JNEUROSCI.2250-06.2006 · DOI · Paper page
- Chiu, 2008, Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo, Neuron, 58, 708, 10.1016/j.neuron.2008.04.014 · DOI · Paper page
- Clark, 2015, Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice, Neurobiol. Learn. Mem., 125, 152, 10.1016/j.nlm.2015.09.003 · DOI · Paper page
- Cork, 2015, Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain, Mol Metab, 4, 718, 10.1016/j.molmet.2015.07.008 · DOI · Paper page
- Counts, 2014, Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment, Neuropharmacology, 79, 172, 10.1016/j.neuropharm.2013.10.018 · DOI · Paper page
- Cui, 2014, Amyloid precursor protein mutation disrupts reproductive experience-enhanced normal cognitive development in a mouse model of Alzheimer's disease, Mol. Neurobiol., 49, 103, 10.1007/s12035-013-8503-x · DOI
- D'Amelio, 2012, Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: from animal models to human findings, Prog. Neurobiol., 99, 42, 10.1016/j.pneurobio.2012.07.001 · DOI
- Daschil, 2015, L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse model, Neurobiol. Aging, 36, 1333, 10.1016/j.neurobiolaging.2014.12.027 · DOI · Paper page
- Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200 · DOI · Paper page
- Dewachter, 2009, Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice, Neurobiol. Aging, 30, 241, 10.1016/j.neurobiolaging.2007.06.011 · DOI
- Ehses, 2003, Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase, Endocrinology, 144, 4433, 10.1210/en.2002-0068 · DOI · Paper page
- El-Husseini Ael, 2002, Synaptic strength regulated by palmitate cycling on PSD-95, Cell, 108, 849, 10.1016/S0092-8674(02)00683-9 · DOI · Paper page
- Ferreira, 2012, Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures, Cell Calcium, 51, 95, 10.1016/j.ceca.2011.11.008 · DOI · Paper page
- Francesco, 2015, Altered intrinsic excitability of hippocampal CA1 pyramidal neurons in aged PDAPP mice, Front. Cell. Neurosci., 9, 372
- Frazzini, 2016, Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model, Cell Death Dis., 7, e2100, 10.1038/cddis.2016.18 · DOI · Paper page
- Freiherr, 2013, Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence, CNS Drugs, 27, 505, 10.1007/s40263-013-0076-8 · DOI · Paper page
- Gavello, 2018, Early alterations of hippocampal neuronal firing induced by Abeta42, Cerebr. Cortex, 28, 433
- Gilman, 2003, Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons, J. Neurochem., 87, 1137, 10.1046/j.1471-4159.2003.02073.x · DOI · Paper page
- Girones, 2004, N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease, Free Radic. Biol. Med., 36, 1241, 10.1016/j.freeradbiomed.2004.02.006 · DOI
- Glasgow, 2018, Activity-dependent netrin-1 secretion drives synaptic insertion of GluA1-containing AMPA receptors in the Hippocampus, Cell Rep., 25, 168, 10.1016/j.celrep.2018.09.028 · DOI · Paper page
- Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
- Hölscher, 2016, Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide analogues as novel treatments for Alzheimer's and Parkinson's disease, Cardiovasc. Endocrinol., 5, 93, 10.1097/XCE.0000000000000087 · DOI
- Hölscher, 2018, Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models, Neuropharmacology, 136, 251, 10.1016/j.neuropharm.2018.01.040 · DOI · Paper page
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Hollmann, 1994, Cloned glutamate receptors, Annu. Rev. Neurosci., 17, 31, 10.1146/annurev.ne.17.030194.000335 · DOI · Paper page
- Hoosein, 1984, Identification of glucagon receptors in rat brain, Proc. Natl. Acad. Sci. U. S. A., 81, 4368, 10.1073/pnas.81.14.4368 · DOI · Paper page
- Hu, 2017, Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model, Cell Death Dis., 8, e2717, 10.1038/cddis.2017.140 · DOI · Paper page
- Hu, 2011, BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasions, J. Neurosci., 31, 15597, 10.1523/JNEUROSCI.2445-11.2011 · DOI · Paper page
- Hyman, 2014, Tau propagation, different tau phenotypes, and prion-like properties of tau, Neuron, 82, 1189, 10.1016/j.neuron.2014.06.004 · DOI
- Jiao, 2017, GLP-1/GIP/Gcg receptor Triagonist improves the cognitive behaviors in triple-transgenic mice of Alzheimer's disease, Acta Physiol. Sin., 69, 135
- Kaplan, 1994, Gastric inhibitory polypeptide (GIP) binding sites in rat brain, Peptides, 15, 297, 10.1016/0196-9781(94)90016-7 · DOI
- Kim, 2008, Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2, Mol. Cell Biol., 28, 1644, 10.1128/MCB.00325-07 · DOI · Paper page
- Kim, 2005, J. Biol. Chem., 280, 22297, 10.1074/jbc.M500540200 · DOI · Paper page
- Lee, 2011, Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways, Neuropharmacology, 61, 867, 10.1016/j.neuropharm.2011.06.003 · DOI · Paper page
- Lennox, 2015, Effects of glucose-dependent insulinotropic polypeptide receptor knockout and a high-fat diet on cognitive function and hippocampal gene expression in mice, Mol. Med. Rep., 12, 1544, 10.3892/mmr.2015.3447 · DOI
- Li, 2018, A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease, Hippocampus, 28, 358, 10.1002/hipo.22837 · DOI · Paper page
- Li, 2017, Real-time measurement of Ca2+ flux in hippocampal slice with non-invasive microtest technique, Acta Physiol. Sin., 69, 467
- Lourenco, 2013, TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's beta-amyloid oligomers in mice and monkeys, Cell Metabol., 18, 831, 10.1016/j.cmet.2013.11.002 · DOI · Paper page
- Mark, 1995, Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death, J. Neurosci., 15, 6239, 10.1523/JNEUROSCI.15-09-06239.1995 · DOI · Paper page
- Mayo, 2003, International Union of Pharmacology. XXXV. The glucagon receptor family, Pharmacol. Rev., 55, 167, 10.1124/pr.55.1.6 · DOI · Paper page
- Mittal, 2016, Shared links between type 2 diabetes mellitus and Alzheimer's disease: a review, Diabetes Metab Syndr, 10, S144, 10.1016/j.dsx.2016.01.021 · DOI
- Miyakawa, 1996, Radial maze performance, open-field and elevated plus-maze behaviors in Fyn-kinase deficient mice: further evidence for increased fearfulness, Brain Res Mol Brain Res, 37, 145, 10.1016/0169-328X(95)00300-H · DOI
- Mota, 2014, Dysfunctional synapse in Alzheimer's disease - a focus on NMDA receptors, Neuropharmacology, 76, 16, 10.1016/j.neuropharm.2013.08.013 · DOI · Paper page
- Newcomer, 2000, NMDA receptor function, memory, and brain aging, Dialogues Clin. Neurosci., 2, 219, 10.31887/DCNS.2000.2.3/jnewcomer · DOI · Paper page
- Oddo, 2003, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron, 39, 409, 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
- Pancani, 2009, Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons, J. Neurochem., 109, 1800, 10.1111/j.1471-4159.2009.06107.x · DOI · Paper page
- Putcha, 2011, Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults, J. Neurosci., 31, 17680, 10.1523/JNEUROSCI.4740-11.2011 · DOI · Paper page
- Rönicke, 2011, Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors, Neurobiol. Aging, 32, 2219, 10.1016/j.neurobiolaging.2010.01.011 · DOI · Paper page
- Satoh, 2007, Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory, J. Neurosci., 27, 10765, 10.1523/JNEUROSCI.0117-07.2007 · DOI · Paper page
- Shoelson, 2006, Inflammation and insulin resistance, J. Clin. Invest., 116, 1793, 10.1172/JCI29069 · DOI · Paper page
- Stover, 2012, Lifespan developmental study of the 3xTg-AD mouse model of Alzheimer's disease: the effect of maternal genotype on later life cognitive performance, Dev. Psychobiol., 54
- Stutzmann, 2003, Ca2+ signaling in mouse cortical neurons studied by two-photon imaging and photoreleased inositol triphosphate, J. Neurosci., 23, 758, 10.1523/JNEUROSCI.23-03-00758.2003 · DOI · Paper page
- Sudhof, 1987, A synaptic vesicle protein with a novel cytoplasmic domain and four transmembrane regions, Science, 238, 1142, 10.1126/science.3120313 · DOI · Paper page
- Tai, 2018, Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease, Brain Res., 1678, 64, 10.1016/j.brainres.2017.10.012 · DOI
- Tian, 2016, Resveratrol improves cognitive impairment by regulating apoptosis and synaptic plasticity in streptozotocin-induced diabetic rats, Cell. Physiol. Biochem., 40, 1670, 10.1159/000453216 · DOI · Paper page
- Tu, 2014, Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease, Mol. Neurodegener., 9, 48, 10.1186/1750-1326-9-48 · DOI · Paper page
- Turrigiano, 2004, Homeostatic plasticity in the developing nervous system, Nat. Rev. Neurosci., 5, 97, 10.1038/nrn1327 · DOI · Paper page
- Ueda, 1997, Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals, J. Neurochem., 68, 265, 10.1046/j.1471-4159.1997.68010265.x · DOI · Paper page
- Unger, 1998, Insulin receptors and signal transduction proteins in the hypothalamo-hypophyseal system: a review on morphological findings and functional implications, Histol. Histopathol., 13, 1215
- Verma, 2018, Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders, Expert Opin. Ther. Targets, 22, 615, 10.1080/14728222.2018.1487952 · DOI · Paper page
- Wang, 2014, L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner, Neurobiol. Aging, 35, 88, 10.1016/j.neurobiolaging.2013.07.007 · DOI · Paper page
- Werther, 1987, Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry, Endocrinology, 121, 1562, 10.1210/endo-121-4-1562 · DOI · Paper page
- Wiedenmann, 1985, Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles, Cell, 41, 1017, 10.1016/S0092-8674(85)80082-9 · DOI · Paper page
- Yaka, 2003, Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1, J. Biol. Chem., 278, 9630, 10.1074/jbc.M209141200 · DOI · Paper page
- Yamamoto, 2002, A distinct form of calcium release down-regulates membrane excitability in neocortical pyramidal cells, Neuroscience, 109, 665, 10.1016/S0306-4522(01)00486-9 · DOI
- Yarchoan, 2014, Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease, Diabetes, 63, 2253, 10.2337/db14-0287 · DOI · Paper page
- Zhang, 2011, The AAA+ ATPase Thorase regulates AMPA receptor-dependent synaptic plasticity and behavior, Cell, 145, 284, 10.1016/j.cell.2011.03.016 · DOI · Paper page
- Zhang, 2009, Amyloid β-protein differentially affects NMDA receptor- and GABAA receptor-mediated currents in rat hippocampal CA1 neurons, Prog. Nat. Sci., 19, 963, 10.1016/j.pnsc.2008.11.006 · DOI
- Zhang, 2016, A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Abeta25-35-impaired mouse cognitive function, Psychopharmacology, 233, 599, 10.1007/s00213-015-4133-5 · DOI
Cited by
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Self-citationBeyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Hammoud, R., & Drucker, D. J. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00783-3 · Cited by 244
“Combinatorial therapy with GIPR–GLP1R dual agonists and GIPR– GLP1R–glucagon receptor tri-agonists has also shown superior neuro-protective effects relative to GLP1RA monotherapy in rodent models of Alzheimer disease and Parkinson disease 173,174 .”
Brain insulin resistance: role in neurodegenerative disease and potential for targeting
Hölscher, C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1738383 · Cited by 180
Self-citationAntidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Nowell, J., Blunt, E., Gupta, D., & Edison, P. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101979 · Cited by 179
“In 3xTg-AD mice, a triple agonist effectively improved memory formation and synaptic activity in pyramidal neurons in hippocampal slices (Li et al., 2020a).”
InfluentialIncretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Nowell, J., Blunt, E., & Edison, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01792-4 · Cited by 136
Metadata
- Authors
- Li, T., Jiao, J.-J., Su, Q., Hölscher, C., Zhang, J., Yan, X.-D., Zhao, H.-M., Cai, H.-Y., & Qi, J.-S.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 170
- Pages
- 108042
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W3009658421
- Cited by
- 36
- References
- 30
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Natural Science Foundation of China
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice. https://app.cochat.ai/papers/10.1016/j.neuropharm.2020.108042
- The paper
- Li, T., Jiao, J.-J., Su, Q., Hölscher, C., Zhang, J., Yan, X.-D., Zhao, H.-M., Cai, H.-Y., & Qi, J.-S. (2020). A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.108042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.